Therefore, in addition to intensive research of the NF-κB system and the identification of inhibiting compounds, further investigations are requested to understand the NF-κB molecular network for the development of synergistic complex therapies in gastric cancer. The gene discussed is NFKB1; the disease is gastric cancer.